David Couret
Overview
Explore the profile of David Couret including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simeone P, Auzias G, Lesimple B, Feghaly E, Lefevre J, Takerkart S, et al.
Ann Phys Rehabil Med
. 2025 Jan;
68(4):101927.
PMID: 39889360
No abstract available.
2.
Clain J, Couret D, Bringart M, Meilhac O, Lefebvre dHellencourt C, Diotel N
IBRO Neurosci Rep
. 2025 Jan;
18():16-30.
PMID: 39816479
It is well recognized that type II Diabetes (T2D) and overweight/obesity are established risk factors for stroke, worsening also their consequences. However, the underlying mechanisms by which these disorders aggravate...
3.
Simeone P, Corrias T, Bruder N, Boussen S, Cardoso D, Alonzo A, et al.
Neurocrit Care
. 2024 Oct;
PMID: 39379750
Background: This study focuses on aneurysmal subarachnoid hemorrhage (aSAH) with a high risk of delayed cerebral ischemia (DCI) and acute hydrocephalus (AH). The aim was to compare the performance of...
4.
Couret D, Boussen S, Cardoso D, Alonzo A, Madec S, Reyre A, et al.
Eur Radiol
. 2024 Jun;
34(11):7526-7536.
PMID: 38836940
Background/objectives: Aneurysmal subarachnoid haemorrhage (aSAH) is a life-threatening event with major complications. Delayed cerebral infarct (DCI) occurs most frequently 7 days after aSAH and can last for a prolonged period....
5.
Clain J, Couret D, Bringart M, Lecadieu A, Meilhac O, Lefebvre dHellencourt C, et al.
Eur J Neurosci
. 2024 Apr;
59(11):3009-3029.
PMID: 38576159
Metabolic disorders are risk factors for stroke exacerbating subsequent complications. Rapidly after brain injury, a glial scar forms, preventing excessive inflammation and limiting axonal regeneration. Despite the growing interest in...
6.
Payen J, Launey Y, Chabanne R, Gay S, Francony G, Gergele L, et al.
Lancet Neurol
. 2023 Oct;
22(11):1005-1014.
PMID: 37863590
Background: Optimisation of brain oxygenation might improve neurological outcome after traumatic brain injury. The OXY-TC trial explored the superiority of a strategy combining intracranial pressure and brain tissue oxygen pressure...
7.
Begue F, Chemello K, Veeren B, Lortat-Jacob B, Tran-Dinh A, Zappella N, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902035
SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less...
8.
Treiber G, Guilleux A, Huynh K, Bonfanti O, Flaus-Furmaniuk A, Couret D, et al.
Diabetes Metab
. 2022 Nov;
49(2):101409.
PMID: 36400409
Aim: Subjects with Familial Partial Lipodystrophy type 2 (FPLD2) are at high risk to develop diabetes. To better understand the natural history and variability of this disease, we studied glucose...
9.
Clain J, Couret D, Planesse C, Krejbich-Trotot P, Meilhac O, Lefebvre dHellencourt C, et al.
Brain Sci
. 2022 May;
12(5).
PMID: 35625066
Adiponectin exhibits pleiotropic effects, including anti-inflammatory, anti-apoptotic, anti-oxidant, and neuroprotective ones. Although some studies have documented brain expression in different rodent models of its receptors, AdipoR1 and AdipoR2, their global...
10.
Taile J, Bringart M, Planesse C, Patche J, Rondeau P, Veeren B, et al.
Antioxidants (Basel)
. 2022 May;
11(5).
PMID: 35624723
Metabolic disorders related to obesity and type 2 diabetes are associated with aggravated cerebrovascular damages during stroke. In particular, hyperglycemia alters redox and inflammatory status, leading to cerebral endothelial cell...